Tectonic Therapeutic (TECX) Shares Outstanding (2017 - 2026)

Tectonic Therapeutic (TECX) has reported Shares Outstanding (Entity) for 10 consecutive years, with $18.8 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Shares Outstanding (Entity) rose 0.85% year-over-year to $18.8 million; the TTM figure through Mar 2026 stood at $18.8 million (up 0.85% YoY), while the FY2025 annual figure was $18.7 million, up 120.71% from the prior year.
• Shares Outstanding (Entity) steadied at $18.8 million in Q1 2026 per TECX's latest filing, from $18.7 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $18.8 million in Q1 2026 and bottomed at $3641.0 in Q2 2022.
• Historically, Shares Outstanding (Entity) has averaged $8.1 million across 5 years, with a median of $3.7 million in 2023.
• Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) sank 99.9% — and 2023, when it jumped 101985.54%.
• Tectonic Therapeutic's Shares Outstanding (Entity) stood at $3645.0 in 2022, then surged by 101985.54% to $3.7 million in 2023, then surged by 128.17% to $8.5 million in 2024, then soared by 120.71% to $18.7 million in 2025, then grew by 0.49% to $18.8 million in 2026.
• Business Quant data shows TECX's Shares Outstanding (Entity) at $18.8 million in Q1 2026, $18.7 million in Q4 2025, and $18.7 million in Q3 2025.